Professional Documents
Culture Documents
Retina Report
Retina Report
Vitreous Base
An area of vitreoretinal adhesion which
straddles the pars plana , oro serrata, and
most peripheral retina(3-4mm width)
Anterior hyaloid- anterior border of the
vitreous
Posterior hyaloid- post. border of the
vitreous
Retina and Areas
Optic disc
Macula
Central/peripheral retina
Retinal Vasculature
Choroidal Vessels
Normal Retina
The retina is approximately 0.5 mm thick and lines
the back of the eye.
Optic Nerve and Vessels
Circular to oval
white area
Measures about
2 x 1.5 mm
across.
Major blood
vessels of the
retina radiate
from the center
of the nerve
Optic Nerve
Transmits visual
impulses from
the retina to
the brain.
Visible part of
the optic nerve
is the optic
disc, or optic
nerve head.
Optic Nerve
ON goes through
the lamina
cribrosa, a
fibrous, sieve-like
structure
Lamina cribrosa
forms the base of
the physiologic
cup, the
depression in the
disc.
Cup/Disc
C/D ratio
Rim of ON is
compared in
size with the
cup to get
C/D ratio.
Scale from
0.1 to 0.9
Normal 0.3 or
less
Optic Nerve
Papillary =
ON
Peripapillary
= area of the
retina around
ON.
Optic Nerve disease
Drusens are intrapapillary
refractile bodies, which
Optic disc usually lie deep beneath the
surface of the disc tissue in
drusen childhood and emerge out by
the early teens.
Thus, in children they present
as pseudo-papilloedema and
by teens they can be
recognized
ophthalmoscopically
as waxy pea-like irregular
refractile bodies.
Optic Nerve Disease
“Straight ahead”
vision
Best visual acuity
Cones form a
concentrated area
known as the fovea,
Fovea is center of the
macula
Fovea
Located 2 1/2
disc diameters
to the left of
the disc,
slightly oval-
shaped
blood vessel-
free reddish
spot
Macula
Yellow pigmentation
Acts as a short wavelength
filter,
(Lens also a filter)
Protective mechanism for
avoiding bright light and
especially UV irradiation
damage
Macular Disease
AMD Stargardts
AGE RELATED MACULAR
DEGENERATION (AMD)
Affects people over 55 years
LEADING CAUSE OF IRREVERSIBLE BLINDNESS IN THE DEVELOPED
WORLD
A complex multifactorial progressive disease
May be genetic, involving the complement pathway &
environmental risk factors, including increasing age, white race, &
smokers
CLASSIFICATION OF AMD
1. Early AMD
Characterized by limited drusen, pigmentary change, or retinal
pigment epithelial atrophy
Fluorescein angiography – irregular patterns of RPE hyperplasia &
atrophy
DRUSEN
o Yellow deposits w/in Bruch’s membrane
o Discrete or confluent
o May also be detected as diffuse subretinal deposits, either:
basal laminar deposits formed mainly of collagen-based
material & situated between the plasma & basement
membranes of the retinal pigment epithelium, or basal linear
deposits, consisting of granular lipid-rich material located w/in
the Bruch’s membrane
2. Late AMD
GEOGRAPHIC ATROPHY (“dry”AMD)
o 20% of legal blindness attributable to AMD
o Manifests as well-demarcated areas, larger than 2 disk diameters,
of atrophy of the RPE & photoreceptor cells, allowing direct
visualization of the underlying choroidal vessels
o Accumulation of LIPOFUSCIN– thought to contribute to strophic
changes
o Visual loss – occurs once the fovea is affected
NEOVASCULAR (“wet” AMD)
o Development of choroidal neovascularization or serous retinal
pigment
epithelium detachment
o Choroidal new vessels may grow in a flat cartwheel or sea-fan
configuration
o Permanent loss of central vision ensues.
o Fluorescein angiography should be performed on all patients w/
AMD w/ new onset of reduced vision or distortion, as the most
sensitive method
Prophylactic Therapy
o Oral vitamins and antioxidants daily comprising
500g vitamin C
400 IU vitamin E
15mg betacarotene
80mg zinc
2mg copper
o Smokers taking betacarotene has an increased risk of
developing lung cancer
o Smoking
Risk factor for development of all forms of macular
degeneration
Cessation is thought to reduce the rate of progression
o RETINAL LASER PHOTOCOAGULATION
Reduces the extent of drusen but increases the rate of
choroidal neovascularization
Treatment of Neovascular AMD
o ANTI-VEGF THERAPY – preferred tx for neovascular AMD
o RANIBIZUMAB
Treatment of choice for all forms of neovascular AMD
o ANCHOR trial
Significant benefit over photodynamic therapy (PDT) for
predominant classic lesions
o PEGAPTANIL
Binds the major pathogenic isoform of VEGF
Intravitreal injection administration
o BEVACIZUMAB
Humanized full length monoclonal antibody to VEGF
o CONVENTIONALRETINAL LASER PHOTOCOAGULATION
Direct destruction of a choroidal neovascular membrane
PHOTODYNAMIC THERAPY
intravenous infusion of a photosensitive dye, VERTEPORFIN
Stargardt disease
The ABCR gene produces a
protein involved in energy
transport to and from
photoreceptor cells in the
retina.
Mutations in the ABCR gene,
which cause stargardt
disease, produce a
dysfunctional protein that
cannot perform its transport
function. As a result,
photoreceptor cells
degenerate and vision loss
occurs
Macular Disease
Best’s juvenile,
adult
Best disease, also termed Abnormalities in the eye
vitelliform macular result from a disorder in
dystrophy, is typically an the retinal pigment
autosomal dominant epithelium (RPE). A
disorder, which classically dysfunction of the protein
presents in childhood with bestrophin results in
the striking appearance of abnormal fluid and ion
a yellow or orange yolklike transport by the RPE.
lesion in the macula.
Macular Disease
Coat’s CME
Macular Disease
Nonproliferative retinopathy
Maculopathy
Proliferative retinopathy
2. RETINAL VEIN OCCLUSION
A common and easily diagnosed w/ potentially blinding
complications
Presents w/ sudden painless loss of vision
Clinical appearance varies from a scattered retinal
hemorrhages and cotton-wool spots to a marked hemorrhagic
appearance w/ both deep and superficial retinal hemorrhage,
CENTRAL RETINAL VEIN OCCLUSION (CRVO)
o Retinal abnormalities involve all 4 quadrants of the fundus
BRANCH RETINAL VEIN OCCLUSION (BRVO)
o Confined to one quadrant
o May involve the upper or lower half or just the macula
Major complications
o Reduced vision from macular edema
o Neovascular glaucoma secondary to iris neovascularization
o Retinal neovascularization
Vein Disease
CRVO BRVO
2. RETINAL VEIN OCCLUSION
A common and easily diagnosed w/ potentially blinding
complications
Presents w/ sudden painless loss of vision
Clinical appearance varies from a scattered retinal
hemorrhages and cotton-wool spots to a marked
hemorrhagic appearance w/ both deep and superficial
retinal hemorrhage, w/c rarely may break through into the
vitreous cavity
o Retinal neovascularization
CENTRAL RETINAL VEIN OCCLUSION
o Retinal abnormalities involve all 4 quadrants of the fundus
BRANCH RETINAL VEIN OCCLUSION
o Confined to one quadrant because the occlusion usually
occurs at the site of an arteriovenous crossing o May
involve the upper or lower half (hemispheric branch
retinal vein occlusion), or just the macula (macular
branch retinal vein occlusion)
Major complications
o Reduced vision from macular edema
o Neovascular glaucoma secondary to iris
neovascularization
Treatment
In branch retinal vein occlusion, grid-pattern macular argon
laser photocoagulation may be indicated when vision loss due
to macular edema persists for several months w/o an
spontaneous improvement
Intravitreal injection of anti-VEGF agents or steroids may
be useful
Monthly renibizumab injections for macular edema
secondary to branch and central retinal vein occlusion
Ozurdex (Allergan) with dexamethasone
Increased IOP
o Most commonly reported adverse events during the first
6 months after treatment
IRIS AND RETINAL NEOVASCULARIZATION IN
RETINAL VEIN OCCLUSION
CRAO BRAO
RETINAL ARTERY OCCLUSION (CRAO)
o Causes painless catastrophic visual loss occurring over a period of
SECONDS;
o Caused by antecedent transient visual loss (amaurosis fugax)
o Other causes of central retinal artery occlusion
Arteriosclerosis
Emboli from carotid or cardiac sources
Branch retinal artery occlusion (BRAO)
o Also causes sudden painless visual loss but usually manifesting as
impairment of visual field
o Visual acuity is only reduced if there is foveal involvement
o With retinal opacification is the same as central retinal artery occlusion, but
sometimes accompanied by cotton-wool spots along its border
o Determined by the extent of retinal infarction
o Most often cause is embolic disease
Treatment
Choroidal
neovasc
Choroidal Disease
Chorioderemia Choroideremia is a
condition characterized
by progressive vision
loss that mainly affects
males. The first
symptom of this
condition is usually an
impairment of night
vision (night blindness),
which can occur in early
childhood.
Bruch’s Membrane
If Bruch’s membrane
compromised,
nutrients such as
vitamin A, might not
be able to reach rods
and cones.
Drusen deposits of
extracellular material
Provide space for
SRNV by lifting up the
RPE
Subretinal
neovascularization
SRNV SRNV
abnormal vessels
develop and penetrate
Bruch’s membrane after
it is first damaged by
something else.
Subretinal
neovascularization
SRNV SRNV
AMD correlates with a
thickening of the
membrane with extra-
cellular material
Retinal Pigment Epithelium
RPE
layerof dark tissue
absorbs excess light so that
the photoreceptors can
give a clearer signal
(reduces scattering)
Retinal Pigment Epithelium
Plays a role in "trimming"
photoreceptors -- cones are
"trimmed" at dusk, and rods are
"trimmed" at dawn
Move nutrients to (and waste
from) the photoreceptors to the
choroid.
Bruch's membrane separates the
choroid from the RPE.
Diseases of RPE
RPE
Retinitis Pigmentosa
Degeneration
of rods
Loss of
peripheral
vision
External Limiting
Membrane
Outer Nuclear Layer
Theouter nuclear layer
contains cell bodies of the
rods and cones
Outer Plexiform Layer
The outer
plexiform
layer (OPL)
Connections
between rod
and cones,
and bipolar
cell dendrites
Inner Nuclear Layer
Contains:
Nuclei of bipolar cells
MÜller cells (synthesize and
store glycogen)
Amacrine cell bodies (act
as condensers, as in an
electric circuit)
Inner Plexiform Layer
Ganglion
cell axons
are fibers
that carry
electrical
signal to
the optic
nerve
Nerve Fiber Layer